Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1993-07-07
1996-06-18
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 54, 514 61, 536 21, A61K 31725, C08B 3710
Patent
active
055277853
ABSTRACT:
Selectin receptor binding is modulated by a method which utilizes heparin-like oligosaccharides.
REFERENCES:
patent: 5143712 (1992-09-01), Brandley et al.
patent: 5208253 (1993-05-01), Boschelli et al.
patent: 5211937 (1993-05-01), Brandley et al.
patent: 5227369 (1993-07-01), Rosen et al.
patent: 5268364 (1993-12-01), Kojima et al.
R. M. Nelson et al. J. Clin. Invest., Mar. 1993, vol. 91, 1157-1116.
M. P. Bevilacqua et al. J. Clin. Invest., Feb. 1993, vol. 91, 379-387.
Assays for inhibitors of leukocyte adhesion Steven, et al., Chemical Abstracts, No. 9, 118:390, Mar. 1, 1993.
GMP-140 (P-selectin/CD62) binds to chronically stimulated but not resting CD4+T lymphocytes and regulates their production of proinflammatory cytokines Damle, et al., Eur. J. Immunol., 22:1789-1793, 1992.
Selectins Bevilacqua & Nelson, Perspectives, 91:379-387, Feb. 1993.
Characterization of Human Platelet GMP-140 as a Heparin-Binding Protein Skinner, et al., Biochemical & Biophysical Research Comm., No. 3, 164:1373-1379, Nov. 15, 1989.
GMP-140 Binding to Neutrophils Is Inhibited by Sulfated Glycans Skinner, et al., The Jrnl. of Biological Chemistry, No. 9, 266: 5371-5374, Mar. 25, 1991.
Degradation of Glycosaminoglycans and Fibronectin on Endotoxin-Stimulated Endothelium by Adherent Neutrophils: Relationship to CD11b/CH18 and L-Selectin . . . Klein, et al., The Jrnl. of Infect. Diseases, No. 4, 167:890-898, Apr. 1993.
Calcium-Dependent Heparin-Like ligands for L-Selectin in Nonlymphoid Endothelial Cells Norgard-Sumnicht, et al., Science, 261:480-483, Jul. 23, 1993.
Heparin Oligosaccharides bind L- and P-Selectin and Inhibit Acute Inflammation Nelson, et al., Blood, No. 11, 82:3253-3258, Dec. 1, 1993.
Bevilacqua Michael P.
Linhardt Robert J.
Nelson Richard M.
Fonda Kathleen Kahler
Robinson Douglas W.
The Regents of the University of California
LandOfFree
Selectin receptor modulating compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selectin receptor modulating compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selectin receptor modulating compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-222964